Stockreport

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares  (IINN) 
PDF Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market seg [Read more]